What is included in Biological Process Development Facility Design & Engineering?
It typically includes process and facility planning, cGMP zoning, cleanroom layouts, personnel and material flows, clean utility systems, HVAC pressurization, process piping, automation, safety reviews, and documentation supporting validation. Hixson integrates architecture, engineering, controls, and project delivery disciplines to help clients move from early requirements through construction administration and commissioning support.
How early should Hixson be involved in a process development facility project?
Early involvement is valuable when user requirements, process flows, capacity targets, and regulatory strategies are still being defined. Hixson can help evaluate site conditions, utility infrastructure, cleanroom needs, lab adjacencies, and future expansion options before major capital decisions are locked in, reducing redesign risk and improving long-term facility flexibility.
Can Hixson design facilities for biologics and cell therapy programs?
Yes. Hixson provides cGMP facility design and engineering for biologics, vaccines, recombinant proteins, biosimilars, viral vectors, plasmid DNA, CRISPR, CAR-T, and autologous or allogeneic cell therapy operations. Capabilities include ISO cleanrooms, biosafety containment, single-use equipment integration, clean utilities, material flows, and documentation aligned with regulatory expectations.
Does Hixson support clean utilities and controlled environments?
Yes. Hixson designs clean utility infrastructure such as WFI, USP purified water, clean steam, pure gases, process water, compressed air, and related distribution systems. Controlled environment support includes HVAC design, pressurization, cleanroom classifications, unidirectional flow considerations, environmental monitoring planning, and finish selections appropriate for cGMP operations.
Can Hixson help with modular cGMP facility strategies?
Hixson provides design and engineering for modular cGMP facilities, including pre-engineered cleanroom modules, skid-mounted process units, and modular fit-outs for tenant cGMP space. Modular approaches can help clients improve speed-to-market, increase regulatory predictability, and add flexible capacity for pharmaceutical, biotech, cell and gene therapy, and CMO/CDMO operations.
How does Hixson address compliance during facility design?
Hixson integrates compliance considerations into design rather than treating them as late-stage corrections. Teams consider FDA, EU GMP Annex 1, PIC/S, EMA, OSHA, environmental permitting, biosafety, cGMP documentation, and validation-supporting requirements as applicable. This helps align layouts, systems, materials, workflows, and construction deliverables with operational and regulatory expectations.
Does Hixson provide automation and commissioning support?
Yes. Hixson’s Controls & Automation group supports feasibility assessment, URS and FDS development, network design, electrical control and panel design, PLC programming, HMI development, FAT/SAT, startup, and commissioning. Automation work can be coordinated with process engineering, utility systems, packaging, batching, CIP, material handling, and facility infrastructure.
What makes Hixson different from a general architecture firm?
Hixson is a full-service architecture and engineering firm with 20 integrated in-house technical disciplines and specialized experience in Food & Beverage, Science & Technology, and Workplace sectors. For biotech and process development projects, that means process, building systems, cleanrooms, utilities, automation, project management, estimating, and construction administration can be coordinated from a single source.